Compare NYAX & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | NYAX | HTFL |
|---|---|---|
| Founded | 2005 | 2007 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.2B |
| IPO Year | 2022 | 2025 |
| Metric | NYAX | HTFL |
|---|---|---|
| Price | $46.28 | $48.02 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 10 |
| Target Price | ★ $75.66 | $47.22 |
| AVG Volume (30 Days) | 20.6K | ★ 1.5M |
| Earning Date | 11-18-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 82.37 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $176,034,000.00 |
| Revenue This Year | $29.66 | $41.33 |
| Revenue Next Year | $24.15 | $24.23 |
| P/E Ratio | $89.78 | ★ N/A |
| Revenue Growth | N/A | ★ 39.92 |
| 52 Week Low | $39.17 | $20.13 |
| 52 Week High | $76.86 | $54.32 |
| Indicator | NYAX | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 47.71 | 49.10 |
| Support Level | $45.59 | $46.46 |
| Resistance Level | $50.30 | $52.38 |
| Average True Range (ATR) | 1.09 | 2.68 |
| MACD | 0.19 | -0.37 |
| Stochastic Oscillator | 47.67 | 24.23 |
Nayax Ltd is an end-to-end retail technology platform for unattended commerce. It unifies payments, operations management, and customer engagement tools into a powerful, adaptable platform for modern commerce. It provides solutions that empower businesses to enhance customer experience, accept cashless payments, and manage their operations with a robust Internet of Things (IoT) software platform, helping achieve long-term growth. The company addresses a broad range of retail verticals, including all types of vending machines, coffee machines, unattended checkout counters, self-service kiosks, ticketing machines, car wash stations, gaming machines, amusement rides, laundromats, EV charging stations, and many more.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.